首页> 外文期刊>Journal of experimental & clinical cancer research : >The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex
【24h】

The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex

机译:通过调节SSBP1 / CDK2 / Cyclin E1复合物,循环RNA磷酸盐磷酸化RB促进宫颈癌进展

获取原文
           

摘要

As a novel type of non-coding RNA, circular RNAs (circRNAs) play a critical role in the initiation and development of various diseases, including cancer. However, the exact function of circRNAs in human cervical cancer remains largely unknown. We identified the circRNA signature of upregulated circRNAs between cervical cancer and paired adjacent normal tissues. Using two different cohorts and GEO database, a total of six upregulated circRNAs were identified with a fold change ?2, and P ?0.05. Among these six circRNAs, hsa_circ_0072088 (circZFR) was the only exonic circRNA significantly overexpressed in cervical cancer. Functional experiments were performed to investigate the biological function of circZFR. CircRNA pull-down, circRNA immunoprecipitation (circRIP) and Co-immunoprecipitation (Co-IP) assays were executed to investigate the molecular mechanism underlying the function of circZFR. Functionally, circZFR knockdown represses the proliferation, invasion, and tumor growth. Furthermore, circRNA pull-down experiments combined with mass spectrometry unveil the interactions of circZFR with Single-Stranded DNA Binding Protein 1 (SSBP1). Mechanistically, circZFR bound with SSBP1, thereby promoting the assembly of CDK2/cyclin E1 complexes. The activation of CDK2/cyclin E1 complexes induced p-Rb phosphorylation, thus releasing activated E2F1 leading to cell cycle progression and cell proliferation. Our findings provide the first evidence that circZFR is a novel onco-circRNA and might be a potential biomarker and therapeutic target for cervical cancer patients.
机译:作为一种新型类型的非编码RNA,圆形RNA(Circrnas)在各种疾病的开始和发展中起着关键作用,包括癌症。然而,Circrnas在人宫颈癌中的确切功能仍然很大程度上是未知的。我们鉴定了宫颈癌和相邻正常组织的上调Circrnas的Circrna签名。使用两个不同的群组和地理数据库,共鉴定了六个上调Circrnas,折叠变化& 2和P&?0.05。在这六个CircRNA中,HSA_CIRC_0072088(CIRCZFR)是宫颈癌中唯一显着过表达的外偏振循环。进行功能实验以研究CIRCZFR的生物学功能。 Circrna下拉,CircRNA免疫沉淀(Circrip)和共免疫沉淀(Co-IP)测定被执行以研究Circzfr功能的分子机制。在功能上,Circzfr敲低抑制增殖,侵袭和肿瘤生长。此外,CircRNA下拉实验与质谱相结合,揭示了CircZFR与单链DNA结合蛋白1的相互作用(SSBP1)。机械地,用SSBP1结合的CirczFR,从而促进CDK2 / Cyclin E1络合物的组装。 CDK2 / Cyclin E1复合物的激活诱导P-RB磷酸化,从而释放活化的E2F1,导致细胞周期进展和细胞增殖。我们的调查结果提供了第一种证据,Circzfr是一种新型onco-circrna,并且可能是宫颈癌患者的潜在生物标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号